These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24176512)

  • 1. Quality by Design approach in the development of a solvent-modified micellar electrokinetic chromatography method: finding the design space for the determination of amitriptyline and its impurities.
    Furlanetto S; Orlandini S; Pasquini B; Del Bubba M; Pinzauti S
    Anal Chim Acta; 2013 Nov; 802():113-24. PubMed ID: 24176512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated quality by design and mixture-process variable approach in the development of a capillary electrophoresis method for the analysis of almotriptan and its impurities.
    Orlandini S; Pasquini B; Stocchero M; Pinzauti S; Furlanetto S
    J Chromatogr A; 2014 Apr; 1339():200-9. PubMed ID: 24656544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality by design in the chiral separation strategy for the determination of enantiomeric impurities: development of a capillary electrophoresis method based on dual cyclodextrin systems for the analysis of levosulpiride.
    Orlandini S; Pasquini B; Del Bubba M; Pinzauti S; Furlanetto S
    J Chromatogr A; 2015 Feb; 1380():177-85. PubMed ID: 25582483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin- and solvent-modified micellar electrokinetic chromatography for the determination of captopril, hydrochlorothiazide and their impurities: A Quality by Design approach.
    Pasquini B; Orlandini S; Caprini C; Del Bubba M; Innocenti M; Brusotti G; Furlanetto S
    Talanta; 2016 Nov; 160():332-339. PubMed ID: 27591621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioseparation and impurity determination of ambrisentan using cyclodextrin-modified micellar electrokinetic chromatography: Visualizing the design space within quality by design framework.
    Orlandini S; Pasquini B; Caprini C; Del Bubba M; Douša M; Pinzauti S; Furlanetto S
    J Chromatogr A; 2016 Oct; 1467():363-371. PubMed ID: 27425759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical quality by design in the development of a solvent-modified micellar electrokinetic chromatography method for the determination of sitagliptin and its related compounds.
    Pasquini B; Gotti R; Villar-Navarro M; Douša M; Renai L; Del Bubba M; Orlandini S; Furlanetto S
    J Pharm Biomed Anal; 2021 Aug; 202():114163. PubMed ID: 34052552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical quality by design in the development of a cyclodextrin-modified capillary electrophoresis method for the assay of metformin and its related substances.
    Orlandini S; Pasquini B; Gotti R; Giuffrida A; Paternostro F; Furlanetto S
    Electrophoresis; 2014 Sep; 35(17):2538-45. PubMed ID: 24825800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical quality by design-based development of a capillary electrophoresis method for Omeprazole impurity profiling.
    Modroiu A; Marzullo L; Orlandini S; Gotti R; Hancu G; Furlanetto S
    J Pharm Biomed Anal; 2024 Sep; 248():116295. PubMed ID: 38879949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral capillary zone electrophoresis in enantioseparation and analysis of cinacalcet impurities: Use of Quality by Design principles in method development.
    Pasquini B; Orlandini S; Villar-Navarro M; Caprini C; Del Bubba M; Douša M; Giuffrida A; Gotti R; Furlanetto S
    J Chromatogr A; 2018 Sep; 1568():205-213. PubMed ID: 30005942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin-MEEKC for the analysis of oxybutynin and its impurities.
    Giannini I; Orlandini S; Gotti R; Pinzauti S; Furlanetto S
    Talanta; 2009 Dec; 80(2):781-8. PubMed ID: 19836552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using an innovative combination of quality-by-design and green analytical chemistry approaches for the development of a stability indicating UHPLC method in pharmaceutical products.
    Boussès C; Ferey L; Vedrines E; Gaudin K
    J Pharm Biomed Anal; 2015 Nov; 115():114-22. PubMed ID: 26183807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: a case of a learning process.
    Hubert C; Lebrun P; Houari S; Ziemons E; Rozet E; Hubert P
    J Pharm Biomed Anal; 2014 Jan; 88():401-9. PubMed ID: 24176744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of liquid chromatographic method for the analysis of dabigatran etexilate mesilate and its ten impurities supported by quality-by-design methodology.
    Pantović J; Malenović A; Vemić A; Kostić N; Medenica M
    J Pharm Biomed Anal; 2015; 111():7-13. PubMed ID: 25828507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality by Design oriented development of hydrophilic interaction liquid chromatography method for the analysis of amitriptyline and its impurities.
    Kasagić-Vujanović I; Jančić-Stojanović B
    J Pharm Biomed Anal; 2019 Sep; 173():86-95. PubMed ID: 31125948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quality by design-based approach to a capillary electrokinetic assay for the determination of dextromepromazine and levomepromazine sulfoxide as impurities of levomepromazine.
    Niedermeier S; Scriba GKE
    J Pharm Biomed Anal; 2017 Nov; 146():402-409. PubMed ID: 28926734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical Quality by Design in pharmaceutical quality assurance: Development of a capillary electrophoresis method for the analysis of zolmitriptan and its impurities.
    Orlandini S; Pasquini B; Caprini C; Del Bubba M; Pinzauti S; Furlanetto S
    Electrophoresis; 2015 Nov; 36(21-22):2642-2649. PubMed ID: 25998990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast analysis of glibenclamide and its impurities: quality by design framework in capillary electrophoresis method development.
    Furlanetto S; Orlandini S; Pasquini B; Caprini C; Mura P; Pinzauti S
    Anal Bioanal Chem; 2015 Oct; 407(25):7637-46. PubMed ID: 26297454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation and determination of nimesulide related substances for quality control purposes by micellar electrokinetic chromatography.
    Zacharis CK; Tzanavaras PD; Notou M; Zotou A; Themelis DG
    J Pharm Biomed Anal; 2009 Feb; 49(2):201-6. PubMed ID: 19062217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of potential genotoxic impurities in rabeprazole active pharmaceutical ingredient via Liquid Chromatography-tandem Mass Spectrometry, following quality-by-design principles for method development.
    Iliou K; Malenović A; Loukas YL; Dotsikas Y
    J Pharm Biomed Anal; 2018 Feb; 149():410-418. PubMed ID: 29154196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical Quality by Design-Compliant Development of a Cyclodextrin-Modified Micellar ElectroKinetic Chromatography Method for the Determination of Trimecaine and Its Impurities.
    Marzullo L; Gotti R; Orlandini S; Slavíčková P; Jireš J; Zapadlo M; Douša M; Nekvapilová P; Řezanka P; Furlanetto S
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.